Thumbnail
Access Restriction
Open

Author Kwok, Hoi-Hin ♦ Chan, Lai-Sheung ♦ Poon, Po-Ying ♦ Yue, Patrick Ying-Kit ♦ Wong, Ricky Ngok-Shun
Source United States Department of Energy Office of Scientific and Technical Information
Content type Text
Language English
Subject Keyword APPLIED LIFE SCIENCES ♦ ANGIOGENESIS ♦ GROWTH FACTORS ♦ HEALING ♦ ISCHEMIA ♦ LUCIFERASE ♦ MESSENGER-RNA ♦ OLIGONUCLEOTIDES ♦ RECEPTORS ♦ THERAPY ♦ TIME DEPENDENCE ♦ TYROSINE ♦ WOUNDS
Abstract Therapeutic angiogenesis has been implicated in ischemic diseases and wound healing. Ginsenoside-Rg{sub 1} (Rg{sub 1}), one of the most abundant active components of ginseng, has been demonstrated as an angiogenesis-stimulating compound in different models. There is increasing evidence implicating microRNAs (miRNAs), a group of non-coding RNAs, as important regulators of angiogenesis, but the role of microRNAs in Rg{sub 1}-induced angiogenesis has not been fully explored. In this report, we found that stimulating endothelial cells with Rg{sub 1} could reduce miR-23a expression. In silico experiments predicted hepatocyte growth factor receptor (MET), a well-established mediator of angiogenesis, as the target of miR-23a. Transfection of the miR-23a precursor or inhibitor oligonucleotides validated the inverse relationship of miR-23a and MET expression. Luciferase reporter assays further confirmed the interaction between miR-23a and the MET mRNA 3′-UTR. Intriguingly, ginsenoside-Rg{sub 1} was found to increase MET protein expression in a time-dependent manner. We further demonstrated that ginsenoside-Rg{sub 1}-induced angiogenic activities were indeed mediated through the down-regulation of miR-23a and subsequent up-regulation of MET protein expression, as confirmed by gain- and loss-of-function angiogenic experiments. In summary, our results demonstrated that ginsenoside-Rg{sub 1} could induce angiogenesis by the inverse regulation of MET tyrosine kinase receptor expression through miR-23a. This study has broadened our understanding of the non-genomic effects of ginsenoside-Rg{sub 1,} and provided molecular evidence that warrant further development of natural compound as novel angiogenesis-promoting therapy. - Highlights: • Therapeutic angiogenesis has been implicated in ischemic diseases and wound healing. • Ginsenoside-Rg{sub 1} (Rg{sub 1}) has been demonstrated as an angiogenesis-stimulating compound. • We found that Rg{sub 1} induces angiogenesis by decreasing miR-23a expression. • Hepatocyte growth factor receptor (MET) is a direct regulatory target of miR-23a. • Rg{sub 1} could induce angiogenesis by the inverse regulation of MET through miR-23a.
ISSN 0041008X
Educational Use Research
Learning Resource Type Article
Publisher Date 2015-09-15
Publisher Place United States
Journal Toxicology and Applied Pharmacology
Volume Number 287
Issue Number 3


Open content in new tab

   Open content in new tab